Pipeline Moves: CuraSen’s Parkinson’s disease and MCI asset’s advancement prospects change with Phase I updates
Rivus and Madrigal’s respective nonalcoholic steatohepatitis assets are also reviewed by Clinical Trials Arena.
By
Gastrointestinal
Latest in
Gastrointestinal
Pipeline Moves: Roche Phase I suspension plummets further study chances in blood cancers
Celularity in glioblastoma multiforme and Sino Biopharm in gastric cancer are also reviewed by Clinical Trials Arena.
By
Pipeline Moves: J&J ends ulcerative colitis trial, further study chances drop
Clinical Trials Arena reviews a total of six trials, including ones in gram-negative bacterial infections, hepatitis B, and obesity.
By
Regulatory roundup: Albireo ASBT inhibitor shot at further study rises in liver diseases
Roche in ulcerative colitis and Alzamend Neuro in dementia associated with Alzheimer’s disease are also reviewed by GlobalData’s Investigative News…
By
InDex enrols first subject in trial of cobitolimod for ulcerative colitis
The trial will enrol six subjects to assess the systemic uptake of the drug to treat colonic inflammation.
Regulatory roundup: AbbVie’s Phase II fail plunges Alzheimer’s contender’s shot at further study
Avalo in Crohn’s disease and RemeGen in Berger’s disease are also reviewed by GlobalData’s Investigative News team.
By
Asia-Pacific has seen the largest growth in gastrointestinal related trials over the past decade
We've analysed 10 years' worth of clinical trials data from GlobalData to pick out key geographic trends.
By
Regulatory roundup: BMS’s deucravacitinib dives in ulcerative colitis after Phase II fail
AstraZeneca’s Imfinzi in hepatocellular carcinoma and GlaxoSmithKline in parasitic disease are among other assets reviewed by GlobalData’s Investigative News team.
By